Roivant Sciences Ltd. Business Finance Contracts & Agreements

22 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Revenue Interest Purchase and Sale Agreement by and among Dermavant Sciences GmbH, certain purchasers and U.S. Bank National Association as collateral agent,...
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Second Amendment to Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P., dated as of May 24, 2024
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
First Amendment to Credit Agreement by and among Dermavant Sciences Ltd., Dermavant Holdings Limited, Dermavant Sciences IRL Limited, Dermavant Sciences GmbH, certain subsidiaries...
Credit Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Stock Purchase Agreement, by and among Roche Holdings, Inc., Roivant Sciences Ltd., Pfizer Inc. and Telavant Holdings, Inc., dated as of October 22, 2023
Stock Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Form of Common Share Purchase and Sale Agreement
Share Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Amended & Restated Roivant Sciences Ltd. Employee Stock Purchase Plan
Stock Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Investor Rights Agreement dated as of November 21, 2022
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2023
Underwriting Agreement, dated as of February 2, 2023, by and among Roivant Sciences Ltd., Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald...
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Underwriting Agreement, dated as of November 8, 2022, by and among Roivant Sciences Ltd., Cantor Fitzgerald & Co., and the Selling Shareholders named therein
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Investor Rights Agreement, dated as of September 13, 2021, by and among Priovant Holdings, Inc., Roivant Sciences Ltd. and Pfizer Inc
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amendment No. 1 to the Support Agreement, dated as of June 9, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC and certain...
Shareholders Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Form of Transaction Support Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp. and certain shareholders of Roivant...
Shareholders Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Sponsor Support Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC and certain shareholders of...
Shareholders Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Form of Subscription Agreement
Subscription Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Third Amended and Restated Registration Rights Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd. and the parties thereto
Registration Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Common Shares Purchase Agreement, dated February 14, 2022, between Roivant Sciences Ltd. and CF Principal Investments LLC
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Agreement and General Release Between Roivant Sciences Ltd., Roivant Sciences, Inc. and Benjamin Zimmer
Release Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to Funding Agreement dated as of October 11, 2018, by and between Dermavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Funding Agreement, dated as of July 10, 2018, by and between Demavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to the Asset Purchase Agreement, dated as of August 31, 2012, by and between Glaxo Group Limited and Welichem Biotech, Inc
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Asset Purchase Agreement, dated as of May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Asset Purchase Agreement, dated as of July 10, 2018, by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited and Dermavant Sciences GmBH
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021